Aurobindo FDA Monday, October 2, 2006 +0.30 Positive

FDA Approves MELOXICAM — Aurobindo Pharma Limited

Aurobindo Pharma Limited secured FDA approval for its generic Meloxicam, a once-daily NSAID oral tablet. This regulatory clearance positions the company to compete in the market for meloxicam while potentially pressuring the market for branded pain management products.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed